Middle East & Africa Diabetes Care Devices Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028

Analysis – by Type (Glucose Monitoring Devices and Insulin Delivery Devices) and End User (Homecare and Hospitals & Clinics) 


No. of Pages: 148    |    Report Code: BMIRE00025669    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Buy Now
Middle East & Africa Diabetes Care Devices Market
Buy Now

The MEA diabetes care devices market is expected to grow from US$ 1,828.78 million in 2022 to US$ 2,551.55 million by 2028; it is estimated to grow at a CAGR of 4.3% from 2022 to 2028.

The emerging markets in the developing countries provide better opportunities for major players to expand their business. Many diabetes care device market players are focusing on the emerging markets in the MEA region due to the increasing prevalence of diabetes and the growing use of diabetes care devices. In emerging countries, medical science has grown rapidly in the past few decades. Furthermore, diabetes treatment has become so popular and common that people are traveling to developing countries for treatment. This is due to excessively high expenses for healthcare in other countries. For instance, health travelers who visit developing countries for medical reasons save 65–80% on health costs compared to the cost in developed countries. Due to several other factors, diabetes treatment has become very cheap in developing countries. Further, government authorities in countries in the region are focusing on strengthening their medical tourism sector, thereby maximizing the flow of revenue. Therefore, the rising medical tourism in developing nations is anticipated to provide lucrative growth opportunities to players operating in the diabetes care devices market during the forecast period across the region.

 

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA diabetes care devices market. The MEA diabetes care devices market is expected to grow at a good CAGR during the forecast period. 

MEA Diabetes Care Devices Market Revenue and Forecast to 2028 (US$ Million)

MEA Diabetes Care Devices Market Segmentation  

The MEA diabetes care devices market is segmented based on type, end user, and country. Based on type, the market is bifurcated into glucose monitoring devices and insulin delivery devices. The glucose monitoring devices segment would dominate the market in 2022. The glucose monitoring devices segment is further segmented into testing strips, glucometer, lancets, and others. Similarly, the insulin delivery devices segment is categorized into insulin pens, insulin syringes, insulin pumps, and others. Based on end user, the MEA diabetes care devices market is bifurcated into homecare and hospitals & clinics. The homecare segment would dominate the market in 2022. Based on country, the MEA diabetes care devices market has been categorized into the UAE, Saudi Arabia, South Africa, and the Rest of MEA. The UAE would dominate the market in 2022.    

B. Braun Melsungen AG; BD; Dexcom, Inc.; Eli Lilly and Company.; F. Hoffmann-La Roche Ltd.; Insulet Corporation; Medtronic; Novo Nordisk A/S; Tandem Diabetes Care Inc.; and Terumo Corporation are among the leading companies in the MEA diabetes care devices market. 


Middle East & Africa Diabetes Care Devices Strategic Insights

Strategic insights for the Middle East & Africa Diabetes Care Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/middle-east-and-africa-diabetes-care-devices-market-strategic-framework.webp
Get more information on this report

Middle East & Africa Diabetes Care Devices Report Scope

Report Attribute Details
Market size in 2022 US$ 1,828.78 Million
Market Size by 2028 US$ 2,551.55 Million
Global CAGR (2022 - 2028) 4.3%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Type
  • Glucose Monitoring Devices and Insulin Delivery Devices
By End User
  • Homecare and Hospitals & Clinics
Regions and Countries Covered Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • B. Braun Melsungen AG
  • BD
  • Dexcom, Inc.
  • Eli Lilly and Company.
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corporation
  • Medtronic
  • Novo Nordisk A/S
  • Tandem Diabetes Care Inc.
  • Terumo Corporation
  • Get more information on this report

    Middle East & Africa Diabetes Care Devices Regional Insights

    The geographic scope of the Middle East & Africa Diabetes Care Devices refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/middle-east-and-africa-diabetes-care-devices-market-geography.webp
    Get more information on this report

    The List of Companies - Middle East & Africa Diabetes Care Devices Market

    1. B. Braun Melsungen AG
    2. BD
    3. Dexcom, Inc.
    4. Eli Lilly and Company.
    5. F. Hoffmann-La Roche Ltd.
    6. Insulet Corporation  
    7. Medtronic    
    8. Novo Nordisk A/S
    9. Tandem Diabetes Care Inc.
    10. Terumo Corporation 
    Frequently Asked Questions
    How big is the Middle East & Africa Diabetes Care Devices Market?

    The Middle East & Africa Diabetes Care Devices Market is valued at US$ 1,828.78 Million in 2022, it is projected to reach US$ 2,551.55 Million by 2028.

    What is the CAGR for Middle East & Africa Diabetes Care Devices Market by (2022 - 2028)?

    As per our report Middle East & Africa Diabetes Care Devices Market, the market size is valued at US$ 1,828.78 Million in 2022, projecting it to reach US$ 2,551.55 Million by 2028. This translates to a CAGR of approximately 4.3% during the forecast period.

    What segments are covered in this report?

    The Middle East & Africa Diabetes Care Devices Market report typically cover these key segments-

    • Type (Glucose Monitoring Devices and Insulin Delivery Devices)
    • End User (Homecare and Hospitals & Clinics)

    What is the historic period, base year, and forecast period taken for Middle East & Africa Diabetes Care Devices Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Diabetes Care Devices Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in Middle East & Africa Diabetes Care Devices Market?

    The Middle East & Africa Diabetes Care Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • B. Braun Melsungen AG
  • BD
  • Dexcom, Inc.
  • Eli Lilly and Company.
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corporation
  • Medtronic
  • Novo Nordisk A/S
  • Tandem Diabetes Care Inc.
  • Terumo Corporation
  • Who should buy this report?

    The Middle East & Africa Diabetes Care Devices Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East & Africa Diabetes Care Devices Market value chain can benefit from the information contained in a comprehensive market report.